{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:04:41Z","timestamp":1771877081667,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3592,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1093\/annonc\/mdp477","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T01:32:18Z","timestamp":1257471138000},"page":"342-347","source":"Crossref","is-referenced-by-count":53,"title":["Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck"],"prefix":"10.1016","volume":"21","author":[{"given":"L.J.","family":"Wirth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.R.","family":"Posner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.I.","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Busse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"Goguen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.M.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Annino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.B.","family":"Tishler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1093\/annonc\/mdp477_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"issue":"9625","key":"10.1093\/annonc\/mdp477_bb0015","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(08)60728-X","article-title":"Head and neck cancer","volume":"371","author":"Argiris","year":"2008","journal-title":"Lancet"},{"issue":"9208","key":"10.1093\/annonc\/mdp477_bb0020","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"issue":"25","key":"10.1093\/annonc\/mdp477_bb0025","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer","volume":"338","author":"Brizel","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1093\/annonc\/mdp477_bb0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1093\/annonc\/mdp477_bb0035","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0360-3016(01)01544-9","article-title":"Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy\u2014results of a multicentric randomized German trial in advanced head-and-neck cancer","volume":"50","author":"Staar","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"31","key":"10.1093\/annonc\/mdp477_bb0040","doi-asserted-by":"crossref","first-page":"27613","DOI":"10.1074\/jbc.M201119200","article-title":"Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer cell line HT-29","volume":"277","author":"Arico","year":"2002","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1093\/annonc\/mdp477_bb0045","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.2005.05.2829","article-title":"Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum","volume":"24","author":"Brizel","year":"2006","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1093\/annonc\/mdp477_bb0050","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1200\/JCO.2005.04.7225","article-title":"Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls","volume":"24","author":"Mendenhall","year":"2006","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1093\/annonc\/mdp477_bb0055","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/jnci\/92.12.977","article-title":"EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups","volume":"92","author":"van Zandwijk","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1093\/annonc\/mdp477_bb0060","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.radonc.2006.07.031","article-title":"Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence","volume":"80","author":"Nguyen","year":"2006","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1093\/annonc\/mdp477_bb0065","first-page":"807","article-title":"Symptom control issues and supportive care of patients with head and neck cancers","volume":"5","author":"Murphy","year":"2007","journal-title":"Clin Adv Hematol Oncol"},{"issue":"15","key":"10.1093\/annonc\/mdp477_bb0070","first-page":"3579","article-title":"Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer","volume":"53","author":"Grandis","year":"1993","journal-title":"Cancer Res"},{"issue":"11","key":"10.1093\/annonc\/mdp477_bb0075","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jnci\/90.11.824","article-title":"Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival","volume":"90","author":"Grandis","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"24","key":"10.1093\/annonc\/mdp477_bb0080","first-page":"7350","article-title":"Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma","volume":"62","author":"Ang","year":"2002","journal-title":"Cancer Res"},{"issue":"17","key":"10.1093\/annonc\/mdp477_bb0085","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1200\/JCO.2005.05.4577","article-title":"Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck","volume":"24","author":"Cohen","year":"2006","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1093\/annonc\/mdp477_bb0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/0955300031000114747","article-title":"Epidermal growth factor receptor and its inhibition in radiotherapy: in vivo findings","volume":"79","author":"Milas","year":"2003","journal-title":"Int J Radiat Biol"},{"issue":"13","key":"10.1093\/annonc\/mdp477_bb0095","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1200\/JCO.2001.19.13.3234","article-title":"Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer","volume":"19","author":"Robert","year":"2001","journal-title":"J Clin Oncol"},{"issue":"14S","key":"10.1093\/annonc\/mdp477_bb0100","first-page":"488s","article-title":"Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent\/metastatic squamous cell carcinoma of the head and neck (SCCHN): results of a phase II study","volume":"22","author":"Trigo","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"1","key":"10.1093\/annonc\/mdp477_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1040-8428(00)00134-7","article-title":"Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy","volume":"38","author":"Yang","year":"2001","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1093\/annonc\/mdp477_bb0110","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ijrobp.2003.09.098","article-title":"Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody","volume":"58","author":"Foon","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"10.1093\/annonc\/mdp477_bb0115","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1200\/JCO.2004.11.061","article-title":"Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer","volume":"22","author":"Rowinsky","year":"2004","journal-title":"J Clin Oncol"},{"issue":"13","key":"10.1093\/annonc\/mdp477_bb0120","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1200\/JCO.2006.08.1620","article-title":"Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer","volume":"25","author":"Van Cutsem","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdp477_bb0125","doi-asserted-by":"crossref","first-page":"S615","DOI":"10.1016\/j.ijrobp.2007.07.1934","article-title":"Panitumumab, a fully human anti-EGFR monoclonal antibody, augments radiation response in xenograft models of upper aerodigestive tract cancers","volume":"69","author":"Kruser","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1093\/annonc\/mdp477_bb0130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/01.LGT.0000171666.71600.9E","article-title":"Type-specific HPV testing as a predictor of high-grade squamous intraepithelial lesion outcome after cytologic abnormalities","volume":"9","author":"Medeiros","year":"2005","journal-title":"J Low Genit Tract Dis"},{"issue":"26","key":"10.1093\/annonc\/mdp477_bb0135","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1200\/JCO.2007.13.3983","article-title":"Evaluation of early and late toxicities in chemoradiation trials","volume":"25","author":"Bentzen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1093\/annonc\/mdp477_bb0140","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMc071075","article-title":"Severe cutaneous reaction during radiation therapy with concurrent cetuximab","volume":"357","author":"Budach","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdp477_bb0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1748-717X-3-5","article-title":"Severe skin reaction secondary to concomitant radiotherapy plus cetuximab","volume":"3","author":"Berger","year":"2008","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdp477_bb0150","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2008.09.007","article-title":"High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes","volume":"90","author":"Giro","year":"2009","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdp477_bb0155","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2008.09.018","article-title":"Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer","volume":"90","author":"Pryor","year":"2009","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdp477_bb0160","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ijrobp.2007.07.023","article-title":"A phase III trial to compare standard versus accelerated fractionation in combination with concurrent cisplatin for head and neck carcinomas (RTOG 0129): report of compliance and toxicity","volume":"69","author":"Ang","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1093\/annonc\/mdp477_bb0165","first-page":"3187","article-title":"Human papillomavirus type 16 and squamous cell carcinoma of the head and neck","volume":"8","author":"Ringstrom","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1093\/annonc\/mdp477_bb0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341938771X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341938771X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/2\/342\/931681\/mdp477.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:16:03Z","timestamp":1624518963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341938771X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S092375341938771X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdp477","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}